EV/EBITDA
-3.70
0.000.00%
90 min ago
Summary
- As of March 12, 2025, URGN EV/EBITDA is -3.70, unchanged from the previous trading day.
- Over the past year, URGN EV/EBITDA has increased by +3.69 (+49.93%).
- URGN EV/EBITDA is now -103.27% below its all-time high of 113.14.
Performance
URGN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
URGN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | 0.0% | 0.0% |
| 1 m1 month | -4.8% | +4.9% | +4.3% |
| 3 m3 months | +6.3% | -6.3% | -5.7% |
| 6 m6 months | +19.2% | -6.0% | -18.0% |
| ytdytd | -0.3% | +0.1% | +0.1% |
| 1 y1 year | +49.9% | -32.6% | -38.6% |
| 5 y5 years | -16.4% | +18.6% | -41.5% |
URGN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.4% | -3.76 | +1.6% | |
| 3 m | 3-month | -3.10 | -19.4% | -4.01 | +7.7% |
| 6 m | 6-month | -3.10 | -19.4% | -5.70 | +35.1% |
| 1 y | 1-year | -3.10 | -19.4% | -7.95 | +53.5% |
| 3 y | 3-year | -0.75 | -393.3% | -8.42 | +56.1% |
| 5 y | 5-year | -0.75 | -393.3% | -8.42 | +56.1% |
| alltime | all time | 113.14 | -103.3% | -244.10 | +98.5% |
UroGen Pharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.70(+0.3%) |
| 2024 | -3.69(-38.5%) |
| 2023 | -6.00(+135.3%) |
| 2022 | -2.55(+62.4%) |
| Date | Value |
|---|---|
| 2021 | -1.57(-43.7%) |
| 2020 | -2.79(-53.9%) |
| 2019 | -6.05(-22.2%) |
| 2018 | -7.78(-67.6%) |
| 2017 | -24.04 |
FAQ
- What is UroGen Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for UroGen Pharma?
- What is URGN EV/EBITDA year-to-date change?
- What is UroGen Pharma EV/EBITDA year-on-year change?
What is UroGen Pharma EV/EBITDA?
The current EV/EBITDA of URGN is -3.70
What is the all time high EV/EBITDA for UroGen Pharma?
UroGen Pharma all-time high EV/EBITDA is 113.14
What is URGN EV/EBITDA year-to-date change?
UroGen Pharma EV/EBITDA has changed by -0.01 (-0.27%) since the beginning of the year
What is UroGen Pharma EV/EBITDA year-on-year change?
Over the past year, URGN EV/EBITDA has changed by +3.69 (+49.93%)